Davunetide
Investigational — tiny support rods inside nerve cells-stabilizing peptide (NAP); not approved.
What it's for
Investigational — tiny support rods inside nerve cells-stabilizing peptide (NAP); not approved.
What it's for
Davunetide (NAP) is an eight–amino-acid peptide derived from activity-dependent neuroprotective protein (ADNP).
What it does for the body
It has been studied for possible neuroprotective effects in disorders involving tiny support rods inside nerve cells and tangled tau protein problems inside brain cells. It is not an approved treatment for Alzheimer’s disease, PSP, or other dementias.
What it targets
Proposed mechanisms include stabilizing tiny support rods inside nerve cells and reducing tangled tau protein problems inside brain cells signals in neuronal models, aiming to protect nerve-connection structure.
Research context
Bottom line for readers: Davunetide is still being studied in people. Watch for peer-reviewed trial readouts and regulator decisions — not just social-media summaries.
Studied for (literature interest)
- Brain research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Davunetide — FDA.gov search
- ClinicalTrials.gov search: Davunetide — U.S. clinical trials registry
- Drugs@FDA search: Davunetide — FDA drug database (if approved)
- PubMed search: Davunetide — NCBI PubMed
- PubMed Central search: Davunetide — NCBI PMC